Symbiosis C.M.
Symbiosis C.M.

Symbiosis C.M.

Measured by StartupHub.aiAgent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed68Site Speed: 68/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust87Data Trust: 87/100. Top 25%. Measured by StartupHub.ai. Median 61.

Medical device company addressing anatomical variability in valvular heart disease.

2021ActiveBoston, United States

About

Symbiosis C.M. is an innovative medical device company focused on solving the challenges posed by anatomical variability in valvular heart disease. Their solutions aim to improve the fit and performance of existing medical devices and to create standalone products for anatomies with significant inter-patient variation.

Key facts

Website
symbiosiscm.com
Headquarters
Boston, United States
Founded
2021
Total funding
$10M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Symbiosis C.M.
DateRoundAmountLead investors
21 Sept 2021Seed$10MMassVentures

Symbiosis C.M. scores 34. Does yours?

That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Symbiosis C.M. trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Symbiosis C.M. is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Symbiosis C.M. raised?

Symbiosis C.M. has raised a total of $10M in funding. The most recent round on record is Seed.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Symbiosis C.M.